Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New therapeutic strategies for treatment of inflammatory bowel disease.
Atreya R, Neurath MF. Atreya R, et al. Mucosal Immunol. 2008 May;1(3):175-82. doi: 10.1038/mi.2008.7. Epub 2008 Mar 5. Mucosal Immunol. 2008. PMID: 19079177 Review.
Rationale for IL-36 receptor antibodies in ulcerative colitis.
Neufert C, Neurath MF, Atreya R. Neufert C, et al. Among authors: atreya r. Expert Opin Biol Ther. 2020 Apr;20(4):339-342. doi: 10.1080/14712598.2020.1695775. Epub 2019 Nov 27. Expert Opin Biol Ther. 2020. PMID: 31773994 No abstract available.
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab.
Scarozza P, Marafini I, Laudisi F, Troncone E, Schmitt H, Lenti MV, Costa S, Rocchetti I, De Cristofaro E, Salvatori S, Frezzati L, Di Sabatino A, Atreya R, Neurath MF, Calabrese E, Monteleone G. Scarozza P, et al. Among authors: atreya r. J Clin Med. 2020 Feb 1;9(2):385. doi: 10.3390/jcm9020385. J Clin Med. 2020. PMID: 32024071 Free PMC article.
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Atreya R, et al. Nat Med. 2000 May;6(5):583-8. doi: 10.1038/75068. Nat Med. 2000. PMID: 10802717
Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression.
Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, Schipp M, Bartsch B, Atreya R, Schmitt E, Galle PR, Renz H, Neurath MF. Finotto S, et al. Among authors: atreya r. J Exp Med. 2001 Jun 4;193(11):1247-60. doi: 10.1084/jem.193.11.1247. J Exp Med. 2001. PMID: 11390432 Free PMC article.
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes.
Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, Lehr HA, Wirtz S, Becker C, Atreya R, Mudter J, Hildner K, Bartsch B, Holtmann M, Blumberg R, Walczak H, Iven H, Galle PR, Ahmadian MR, Neurath MF. Tiede I, et al. Among authors: atreya r. J Clin Invest. 2003 Apr;111(8):1133-45. doi: 10.1172/JCI16432. J Clin Invest. 2003. PMID: 12697733 Free PMC article.
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
Atreya R, Neurath MF. Atreya R, et al. Clin Rev Allergy Immunol. 2005 Jun;28(3):187-96. doi: 10.1385/CRIAI:28:3:187. Clin Rev Allergy Immunol. 2005. PMID: 16129903 Review.
Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
Atreya R, Atreya I, Neurath MF. Atreya R, et al. Among authors: atreya i. Ann N Y Acad Sci. 2006 Aug;1072:98-113. doi: 10.1196/annals.1326.001. Ann N Y Acad Sci. 2006. PMID: 17057193 Review.
Exacerbation of ulcerative colitis after rituximab salvage therapy.
Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF. Goetz M, et al. Among authors: atreya r. Inflamm Bowel Dis. 2007 Nov;13(11):1365-8. doi: 10.1002/ibd.20215. Inflamm Bowel Dis. 2007. PMID: 17604367
Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
Atreya R, Neurath MF. Atreya R, et al. Curr Drug Targets. 2008 May;9(5):369-74. doi: 10.2174/138945008784221116. Curr Drug Targets. 2008. PMID: 18473764 Review.
161 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback